Product Overview
DUROLANE® 3 mL is a single-injection hyaluronic acid (HA) joint therapy designed for the symptomatic relief of mild to moderate osteoarthritis (OA) pain. Formulated with stabilized, ultra-pure hyaluronic acid, DUROLANE supplements depleted synovial fluid in affected joints—restoring natural cushioning, shock absorption, and lubrication directly at the source of discomfort.
Unlike daily oral pain medications or repeated corticosteroid injections, DUROLANE provides effective, targeted pain relief that is clinically proven to last up to 6 months following a single office procedure.
About This Item
-
Single-Treatment Convenience: Delivers long-lasting osteoarthritis pain relief in a single 3 mL intra-articular injection, eliminating the need for multi-visit injection schedules.
-
Clinically Documented: Backed by over 20 clinical studies and used in more than 2,000,000 treatments worldwide.
-
Targeted OA Relief: Restores the lubricating and protective properties of healthy synovial joint fluid to improve mobility and reduce pain.
-
Safe Alternative to Steroids & Oral Painkillers: Provides targeted joint therapy without the systemic side effects of daily oral NSAIDs/COX-2 inhibitors or the risk of cartilage loss associated with repeated steroid injections.
-
Broad Joint Indications (EU/UK): Approved for mild to moderate osteoarthritis pain in the knee, hip, ankle, shoulder, elbow, wrist, fingers, and toes, as well as post-arthroscopy pain within 3 months of procedure.
Indications & Usage
-
Primary Indications: Symptomatic treatment of mild to moderate osteoarthritis in the knee, hip, ankle, shoulder, elbow, wrist, fingers, and toes.
-
Post-Surgical Application: Indicated for joint pain following arthroscopy in the presence of osteoarthritis within 3 months of the surgical procedure.
-
Administration: To be administered by a qualified healthcare professional directly into the joint space via intra-articular injection.
Summary of Safety & Risks
-
Contraindications: Do not administer to patients with active skin disease, infections, or open wounds at or near the injection site.
-
Special Populations: DUROLANE has not been tested in pregnant women, lactating mothers, or pediatric populations.
-
Adverse Reactions: Potential post-injection side effects are typically transient and may include localized mild pain, swelling, or joint stiffness at the injection site.
Product Specifications
-
Brand Name: DUROLANE®
-
Manufacturer: Bioventus LLC
-
Volume: 3.0 mL pre-filled syringe
-
Active Ingredient: High molecular weight stabilized Hyaluronic Acid (HA)
-
Regulatory Classification: Class III Medical Device (CE / UKCA Marked)
-
Regulatory Notice: This product is strictly classed as a medical device (not a medicine).